Beth D. Youngblood

473 total citations
13 papers, 238 citations indexed

About

Beth D. Youngblood is a scholar working on Cellular and Molecular Neuroscience, Sensory Systems and Molecular Biology. According to data from OpenAlex, Beth D. Youngblood has authored 13 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 6 papers in Sensory Systems and 4 papers in Molecular Biology. Recurrent topics in Beth D. Youngblood's work include Neurobiology and Insect Physiology Research (6 papers), Ion Channels and Receptors (6 papers) and Ion channel regulation and function (3 papers). Beth D. Youngblood is often cited by papers focused on Neurobiology and Insect Physiology Research (6 papers), Ion Channels and Receptors (6 papers) and Ion channel regulation and function (3 papers). Beth D. Youngblood collaborates with scholars based in United States, Hungary and Switzerland. Beth D. Youngblood's co-authors include Sonya G. Lehto, Narender R. Gavva, Weiya Wang, Maosheng Zhang, Valéria Tékus, Erika Pintér, Weiya Wang, András Garami, Eszter Pákai and Laurie B. Schenkel and has published in prestigious journals such as Journal of Neuroscience, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Beth D. Youngblood

12 papers receiving 223 citations

Peers

Countries citing papers authored by Beth D. Youngblood

Since Specialization

Citations

This map shows the geographic impact of Beth D. Youngblood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth D. Youngblood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth D. Youngblood more than expected).

Fields of papers citing papers by Beth D. Youngblood

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth D. Youngblood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth D. Youngblood. The network helps show where Beth D. Youngblood may publish in the future.

Co-authorship network of co-authors of Beth D. Youngblood

This figure shows the co-authorship network connecting the top 25 collaborators of Beth D. Youngblood. A scholar is included among the top collaborators of Beth D. Youngblood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth D. Youngblood. Beth D. Youngblood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive–compulsive disorder (OCD)-like behaviors 2023 ·Frontiers in Psychiatry ·Beth D. Youngblood, Julio C. Medina, Donald R. Gehlert, Neil Schwartz	0
2	Novel series of tunable µOR modulators with enhanced brain penetration for the treatment of opioid use disorder, pain and neuropsychiatric indications 2023 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Thomas T. Nguyen, (unknown), Ulhas Bhatt, Kevin Li, Yihong Li, Pingyu Ding, Frederick J. Seidl, (unknown), J. Jack Lee, (unknown), (unknown), (unknown), David Sperandio, Lawrence R. McGee, Beth D. Youngblood, Neil Schwartz, Donald R. Gehlert, (unknown)	1
3	Discovery of pyridyl urea sulfonamide inhibitors of NaV1.7 2022 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Benjamin C. Milgram, R. Foti, Thomas Kornecook, Joseph Ligutti, Bryan D. Moyer, (unknown), Beth D. Youngblood, Violeta Yu, Roman Shimanovich, Alessandro A. Boezio, Matthew M. Weiss	1
4	Modulation of Ligand-Gated Glycine Receptors Via Functional Monoclonal Antibodies 2022 ·Journal of Pharmacology and Experimental Therapeutics ·Jeffrey R. Simard, Klaus Michelsen, Yan Wang, Chunhua Yang, Beth D. Youngblood, (unknown), (unknown), (unknown), Kevin D. Cook, (unknown), Alexander Long, Brian E. Hall, P.L. Shaffer, R. Foti, Jacinthe Gingras	1
5	A Novel Maintenance Therapeutic for Opioid Use Disorder 2021 ·Journal of Pharmacology and Experimental Therapeutics ·Beth D. Youngblood, Kevin Li, Donald R. Gehlert, Julio C. Medina, Neil Schwartz	3
6	Rat Na_V1.7 loss-of-function genetic model: Deficient nociceptive and neuropathic pain behavior with retained olfactory function and intra-epidermal nerve fibers 2019 ·Molecular Pain ·(unknown), (unknown), Matthew Alsaloum, Nishi Rampal, (unknown), Cheng Yang, (unknown), (unknown), Beth D. Youngblood, Danxia Liu, Elizabeth J. Galbreath, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sulayman D. Dib‐Hajj, Jacinthe Gingras	26
7	Discovery and hit-to-lead evaluation of piperazine amides as selective, state-dependent Na_V1.7 inhibitors 2016 ·MedChemComm ·Brian A. Sparling, (unknown), Jessica Able, Howard Bregman, Erin F. DiMauro, R. Foti, Hua Gao, Angel Guzmán-Pérez, Hongbing Huang, (unknown), Thomas Kornecook, Joseph Ligutti, Benjamin C. Milgram, Bryan D. Moyer, Beth D. Youngblood, Violeta Yu, Matthew M. Weiss	4
8	Selective antagonism of TRPA1 produces limited efficacy in models of inflammatory- and neuropathic-induced mechanical hypersensitivity in rats 2016 ·Molecular Pain ·Sonya G. Lehto, Andy Weyer, Beth D. Youngblood, Maosheng Zhang, Ruoyuan Yin, Weiya Wang, Yohannes Teffera, (unknown), Cheryl L. Stucky, Laurie B. Schenkel, Stephanie Geuns-Meyer, Bryan D. Moyer, Kenneth D. Wild, Narender R. Gavva	21
9	Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity 2016 ·Journal of Medicinal Chemistry ·Laurie B. Schenkel, Philip R. Olivieri, Alessandro A. Boezio, Holly L. Deak, Renee Emkey, Russell F. Graceffa, Hakan Günaydin, Angel Guzmán-Pérez, Josie H. Lee, Yohannes Teffera, Weiya Wang, Beth D. Youngblood, Violeta Yu, Maosheng Zhang, Narender R. Gavva, Sonya G. Lehto, Stephanie Geuns-Meyer	40
10	AMG2850, a potent and selective TRPM8 antagonist, is not effective in rat models of inflammatory mechanical hypersensitivity and neuropathic tactile allodynia 2015 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Sonya G. Lehto, Andy Weyer, Maosheng Zhang, Beth D. Youngblood, Luyu Wang, Weiya Wang, Patrick C. Kerstein, Carl D. Davis, Kenneth D. Wild, Cheryl L. Stucky, Narender R. Gavva	24
11	Development of novel azabenzofuran TRPA1 antagonists as in vivo tools 2014 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Alessandro A. Boezio, Eugene Cheung, (unknown), Philip R. Olivieri, Laurie B. Schenkel, Qian Wan, Weiya Wang, Mary C. Wells, Beth D. Youngblood, Narender R. Gavva, Sonya G. Lehto, Stephanie Geuns-Meyer	19
12	Transient Receptor Potential Channel Ankyrin-1 Is Not a Cold Sensor for Autonomic Thermoregulation in Rodents 2014 ·Journal of Neuroscience ·Cristiane de Oliveira, András Garami, Sonya G. Lehto, Eszter Pákai, Valéria Tékus, Krisztina Pohóczky, Beth D. Youngblood, Weiya Wang, Michael E. Kort, Philip R. Kym, Erika Pintér, Narender R. Gavva, Andrej A. Romanovsky	62
13	Optimization of Potency and Pharmacokinetic Properties of Tetrahydroisoquinoline Transient Receptor Potential Melastatin 8 (TRPM8) Antagonists 2014 ·Journal of Medicinal Chemistry ·Daniel B. Horne, Nuria Tamayo, Michael D. Bartberger, Yunxin Bo, (unknown), Carl D. Davis, Vijay Gore, Matthew R. Kaller, Sonya G. Lehto, (unknown), Nobuko Nishimura, Thomas T. Nguyen, (unknown), Weiya Wang, Beth D. Youngblood, Maosheng Zhang, Narender R. Gavva, Holger Monenschein, Mark H. Norman	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact